Later Life & Neurocognitive Disorders

Distinguish between prevalent misconceptions and well-supported findings regarding age-related changes


  • Common issues later in life:

    • Physical decline

    • Sensory deficits

    • Loss of loved ones

    • Social stigma

    • 80% of elderly individuals have at least one major medical condition

    • Impacts on sleep quality

    • Polypharmacy

      • Increased risk of side effects

 

Understand the prevalence of psychological disorders in older adults and the challenges associated with them

  • People over age 65 have the lowest prevalence of psychological disorders

  • Comorbidity is more common in the elderly than in younger adults

  • Schizophrenia and PDs are less frequent among older adults

  • Most late-life psychological disorders are recurrences, not new onsets

  • 97% of older adults with generalised anxiety disorder and 90% with major depressive disorder or agoraphobia had symptoms before age 65

 

Gain insight into common neurocognitive disorders experienced in later life

  • Dementia (Major Neurocognitive Disorder): Umbrella term for a syndrome involving progressive cognitive decline which causes functional impact


  • In 2010, global dementia prevalence was 35.6 million, expected to rise to 65.7 million by 2030


  • Mild Cognitive Impairment (MCI) - Minor Neurocognitive Disorder: Diagnostic category indicating cognitive decline without functional impairment

    • Divided into two types:

      • Amnestic MCI (primarily affecting memory)

      • Non-amnestic MCI (affecting other cognitive functions)


 


 


 

Develop a foundational understanding of various forms of dementia and neurodegenerative conditions, including their aetiology, neuropathology, symptoms, and treatment/management strategies

  • Alzheimer's Disease (AD): Characterized by progressive cognitive deterioration which affects:

    • Memory

    • Language

    • Praxis

    • Visuospatial abilities

    • Executive skills

      • Insidious onset: symptoms have a gradual onset over months/years (2-3 years before diagnosis)

    • Mild symptoms:

      • Language deterioration and word finding difficulty

      • Advancing memory difficulties

      • Increased visuospatial difficulties

      • Decreased reasoning, problem-solving, and judgement

      • Increased likelihood of apathy/depression

    • Advanced symptoms:

      • Severe memory loss

      • Severe functional decline (dependent on full-time care)

      • Agitation

      • Communication difficulty

      • Inability to recognise loved ones

      • Being unaware of surroundings

      • Reduced physical function

      • Increased vulnerability to infections/pneumonia

    • Pathophysiology:

      • Characterised by the accumulation of beta-amyloid plaques (deposits outside neurons) and neurofibrillary tangles (twisted filaments of tau protein within neurons)

        • Lead to inflammation and cell death

        • Plaques are most densely found in the frontal cortex

        • Tangles are concentrated in the hippocampus (critical for memory)


 


  • ApoE-4 allele on chromosome 19 appears to hinder the clearance of beta-amyloid from the brain

    • One increases risk to about 20%

  • Frontotemporal Dementia (FTD): Encompasses a range of non-Alzheimer's dementias characterised by atrophy in the frontal and anterior temporal regions of the brain

    • Behavioural Variant FTD (bvFTD): Characterised by significant changes in personality and social behaviour

      • Symptoms:

        • Disinhibition

        • Apathy

        • Loss of empathy

        • Impulsivity

        • Socially inappropriate behaviour

    • Progressive Nonfluent Aphasia (PNFA): Characterised by effortful speech and grammatical difficulties, often with agrammatism (omission of words, trouble with verb tenses)

    • Semantic Dementia (SD): Involves a loss of word comprehension and difficulty in naming objects, leading to impaired conceptual knowledge

  • Vascular Dementia (VD): Caused by cerebrovascular disease, primarily from strokes that lead to neuron death

    • Risk factors:

      • Cardiovascular risk factors

      • High cholesterol

      • Smoking

      • High blood pressure

    • Cognitive profile:

      • Poor EF

      • Speed of thinking

      • Mild memory impairments

      • Gait disturbances

      • History of falls

      • Progressive functional decline

  • Dementia with Lewy Bodies (DLB): Progressive neurodegenerative disorder characterised by the presence of abnormal protein deposits known as Lewy bodies in the brain

    • Symptoms:

      • Fluctuating cognition and alertness

      • Motor features of parkinsonism

      • Visual hallucinations

      • REM sleep behaviour disorder

      • Autonomic symptoms (e.g. sweating, hypersomnia)

      • Delirium

  • Delirium: Characterised by acute confusion and fluctuating cognition/levels of alertness

    • Daily fluctuations in presentation is often what distinguishes delirium from other conditions

    • Caused due to medical symptoms or substance induced

    • Symptoms:

      • Mood symptoms

      • Agitation

      • Psychotic symptoms

      • Sleep disturbances

    • If left untreated, mortality rate is high

 

Understand the roles of psychologists and neuropsychologists in the management of these conditions

  • Detailed cognitive assessment

  • Differential diagnosis (distinguishes between normal aging and neurodegenerative disease)

  • Care planning and rehabilitation guidance